Literature DB >> 10537223

"Rational hope" in the early treatment of Parkinson's disease.

T L Sourkes1.   

Abstract

The drug treatment of Parkinson's disease since the original description of the malady in 1817 is described. Consideration is given to the historic use of alkaloids of the belladonna, harmala, and aporphine families, and of amphetamine. The introduction of the L-dopa treatment is described. The modes of action of the various drugs employed in the past as well as those in current use are described in the context of knowledge of the functioning of the nigrostriatal tract.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10537223

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  6 in total

1.  Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression.

Authors:  Yun Li; Rita Sattler; Eun Ju Yang; Alice Nunes; Yoko Ayukawa; Sadia Akhtar; Grace Ji; Ping-Wu Zhang; Jeffrey D Rothstein
Journal:  Neuropharmacology       Date:  2010-10-27       Impact factor: 5.250

2.  Role of muscarinic receptors in the regulation of immune and inflammatory responses.

Authors:  Seddigheh Razani-Boroujerdi; Muskaan Behl; Fletcher F Hahn; Juan Carlos Pena-Philippides; Julie Hutt; Mohan L Sopori
Journal:  J Neuroimmunol       Date:  2008-01-10       Impact factor: 3.478

3.  Parkinsonism caused by adverse drug reactions: a case series.

Authors:  Solomon O Ugoya; Emmanuel I Agaba; Comfort A Daniyam
Journal:  J Med Case Rep       Date:  2011-03-16

4.  Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain.

Authors:  Gislaine Z Réus; Roberto B Stringari; Cinara L Gonçalves; Giselli Scaini; Milena Carvalho-Silva; Gabriela C Jeremias; Isabela C Jeremias; Gabriela K Ferreira; Emílio L Streck; Jaime E Hallak; Antônio W Zuardi; José A Crippa; João Quevedo
Journal:  Depress Res Treat       Date:  2011-09-29

5.  The β-carboline alkaloid harmine inhibits telomerase activity of MCF-7 cells by down-regulating hTERT mRNA expression accompanied by an accelerated senescent phenotype.

Authors:  Lei Zhao; Michael Wink
Journal:  PeerJ       Date:  2013-10-01       Impact factor: 2.984

6.  Harmine enhances type H vessel formation and prevents bone loss in ovariectomized mice.

Authors:  Jie Huang; Hao Yin; Shan-Shan Rao; Ping-Li Xie; Xu Cao; Tai Rao; Shu-Ying Liu; Zhen-Xing Wang; Jia Cao; Yin Hu; Yan Zhang; Juan Luo; Yi-Juan Tan; Zheng-Zhao Liu; Ben Wu; Xiong-Ke Hu; Tuan-Hui Chen; Chun-Yuan Chen; Hui Xie
Journal:  Theranostics       Date:  2018-03-28       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.